China’s pharmaceutical sector is making headlines again, this time for its robust performance on the Hong Kong Stock Exchange. Jiangsu Hengrui Pharmaceuticals $600276.SS and Mirxes Holdings raised a combined $1.4 billion through separate listings, both seeing significant gains on their first day of trading.